During the past decade, Chapel Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chapel Medical Group" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chapel Medical Group" are "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Chapel Medical Group" in a lesser frequency.

Most popular intervention types in "Chapel Medical Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Salsalate" (2 trials), "Placebo" (1 trials) and "Salsalate Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chapel Medical Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chapel Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chapel Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chapel Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".